Table 1.
2004–2018 Basic Situation of Non-Hodgkin lymphoma Incidence.
2004-2008 (N=52228) | 2009-2013 (N=56010) | 2014-2018 (N=63194) | |
---|---|---|---|
Sex | |||
Male | 27682 (53.0%) | 30312 (54.1%) | 34587 (54.7%) |
Female | 24546 (47.0%) | 25698 (45.9%) | 28607 (45.3%) |
Race | |||
American Indian/Alaska Native | 238 (0.4%) | 322 (0.6%) | 326 (0.5%) |
Asian or Pacific Islander | 3402 (6.5%) | 4223 (7.5%) | 5385 (8.5%) |
Black | 3961 (7.6%) | 4474 (8.0%) | 4949 (7.8%) |
White | 37909 (72.6%) | 38470(68.7%) | 41657 (65.9%) |
Diagnosis age | |||
15-44 | 7697 (14.7%) | 7461 (13.3%) | 7531(11.9%) |
45-54 | 8160 (15.6%) | 8425 (15.0%) | 8299 (13.1%) |
55-64 | 10497 (20.1%) | 12442 (22.2%) | 14535 (23.0%) |
65-74 | 10636 (20.4%) | 12527 (22.4%) | 16336 (25.9%) |
75+ | 15238 (29.2%) | 15155 (27.1%) | 16493 (26.1%) |
Primary Site | |||
Extranodal | 16529 (31.6%) | 19283 (34.4%) | 22511 (35.6%) |
Nodal | 35699(68.4%) | 36727(65.6%) | 40683 (64.4%) |
Area | |||
Rural | 45612(87.3%) | 49625(88.6%) | 56451(89.3%) |
Urban | 6563(12.6%) | 6316(11.3%) | 6697(10.6%) |
Histology | |||
CLL/SLL | 2923 (5.6%) | 2435 (4.3%) | 2843 (4.5%) |
DLBCL | 19379 (37.1%) | 20953 (37.4%) | 23708 (37.5%) |
FL | 9959 (19.1%) | 9788(21.7%) | 10919 (17.3%) |
MCL | 1937 (3.7%) | 2359(4.2%) | 2833 (4.5%) |
MZL | 4575 (8.8%) | 5476 (9.8%) | 6586(10.4%) |
PTCL | 3237 (6.2%) | 3448 (6.2%) | 3716 (5.9%) |